Alyeska Investment Group’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-100,000
| Closed | -$5.42M | – | 604 |
|
|
2024
Q4 | $5.42M | Hold |
100,000
| – | – | 0.02% | 393 |
|
|
2024
Q3 | $5.04M | Sell |
100,000
-25,000
| -20% | -$1.26M | 0.03% | 355 |
|
|
2024
Q2 | $5.5M | Buy |
+125,000
| New | +$5.5M | 0.03% | 324 |
|
|
2024
Q1 | – | Sell |
-50,000
| Closed | -$3.02M | – | 535 |
|
|
2023
Q4 | $3.02M | Buy |
+50,000
| New | +$3.02M | 0.02% | 325 |
|
|
2023
Q3 | – | Sell |
-57,347
| Closed | -$2.92M | – | 550 |
|
|
2023
Q2 | $2.92M | Buy |
+57,347
| New | +$2.92M | 0.02% | 360 |
|
|
2022
Q1 | – | Sell |
-320,000
| Closed | -$3.17M | – | 637 |
|
|
2021
Q4 | $3.17M | Hold |
320,000
| – | – | 0.04% | 364 |
|
|
2021
Q3 | $3.18M | Hold |
320,000
| – | – | 0.04% | 414 |
|
|
2021
Q2 | $3.31M | Hold |
320,000
| – | – | 0.04% | 426 |
|
|
2021
Q1 | $3.26M | Hold |
320,000
| – | – | 0.04% | 384 |
|
|
2020
Q4 | $3.64M | Buy |
+320,000
| New | +$3.64M | 0.05% | 312 |
|